SCHEMBL29139991

SCHEMBL29139991

Nc1ncnc2c1cnn2Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 5/20 0.61
PI4K2B Q8TCG2 5/20 0.61
PI4K2A Q9BTU6 5/20 0.61
PI4KB Q9UBF8 5/20 0.61
KDM4E B2RXH2 2/20 0.53
HSD17B10 Q99714 2/20 0.53
EGFR P00533 2/20 0.53
MEN1 O00255 1/20 0.53
ALDH1A1 P00352 1/20 0.53
CYP1A2 P05177 1/20 0.53
TSHR P16473 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 1/20 0.53
XDH P47989 8/20 0.50
SIGMAR1 Q99720 1/20 0.46
NPC1 O15118 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
BLM P54132 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30788410 1.00 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL1597202 0.76 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL130407 0.76 PI4KA (1.00) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL5025526 0.74 SIGMAR1 (0.64) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL11981833 0.72 XDH (0.64) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL29773082 0.72 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL26658518 0.72 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL27500851 0.72 SIGMAR1 (0.57) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL12206789 0.72 PI4KB (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E
SCHEMBL156688 0.72 PI4KA (0.61) PI4KAPI4K2BPI4K2API4KBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111433205-B Polycyclic compounds as allosteric SHP2 inhibitors 锐新医药公司 2024-01-19 CN disclosed